Additionally, in stage IV MSS cases, the survival of patients harboring TF-positive tumors (mean survival time 0.50 years) was significantly lower than in TF-negative cases (mean survival time 4.67 years) (p = 0.019). The gene discussed is TF; the disease is Marinesco-Sjogren syndrome.